• Aeternum Health posted a GAAP operating loss from continuing operations of USD 270,879 for the quarter ended June 30, 2026.
• No revenue from continuing operations for the quarter, unchanged from the year-earlier period.
• Results included a USD 2.01 million gain on disposal of the discontinued Shorepower business, alongside a USD 13,898 loss from discontinued operations.
• Cash totaled USD 702,809 at June 30, 2026, with working capital of about USD 1.8 million.
• Company flagged substantial doubt about going concern; it expects additional financing as it pivots to critical minerals and longevity-focused development.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aeternum Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-039164), on August 19, 2026, and is solely responsible for the information contained therein.